UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and prevalence of multiple sclerosis in Norway

Acta neurologica Scandinavica, 2012-12, Vol.126 (s195), p.36-42

Midgard, R.

2012

Volltextzugriff (PDF)

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study

Journal of neurology, 2024-04, Vol.271 (4), p.1610-1617

2024

Volltextzugriff (PDF)

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

Multiple sclerosis journal - experimental, translational and clinical, 2019-10, Vol.5 (4), p.2055217319888767-2055217319888767

2019

Volltextzugriff (PDF)

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

European journal of neurology, 2016-06, Vol.23 (6), p.1064-1070

2016

Volltextzugriff (PDF)

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses

European journal of neurology, 2005-12, Vol.12 (12), p.939-946

2005

Volltextzugriff (PDF)

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway

Neurology, 2006-01, Vol.66 (2), p.182-186

2006

Volltextzugriff (PDF)

Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in Møre and Romsdal County, Norway

Neuroepidemiology, 2011-01, Vol.37 (1), p.58-63

2011

Volltextzugriff (PDF)

WT1 and interferon-β-vitamin D association in MS: a longitudinal study

Acta neurologica Scandinavica, 2016-04, Vol.133 (4), p.309-312

2016

Volltextzugriff (PDF)

Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients

Neuroepidemiology, 2012-09, Vol.39 (2), p.84-93

2012

Volltextzugriff (PDF)

Opsoclonus myoclonus syndrome in two cases with neuroborreliosis

European journal of neurology, 2007-12, Vol.14 (12), p.e1-e2

2007

Volltextzugriff (PDF)

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

Multiple sclerosis, 2001-02, Vol.7 (1), p.59-65

2001

Volltextzugriff (PDF)

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

Lancet neurology, 2008-08, Vol.7 (8), p.690-695

2008

Volltextzugriff (PDF)

Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study

Acta neurologica Scandinavica, 2004-06, Vol.109 (6), p.378-384

2004

Volltextzugriff (PDF)

Autoimmune encephalitis in Molde, Western Norway 2004-2017

Journal of the neurological sciences, 2017-10, Vol.381, p.533-533

2017

Volltextzugriff (PDF)

Oligoclonal bands in cerebrospinal fluid:a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index

Acta neurologica Scandinavica, 2000-11, Vol.102 (5), p.322-325

2000

Volltextzugriff (PDF)

Multiple sclerosis and chronic inflammatory diseases A case-control study

Acta neurologica Scandinavica, 1996-05, Vol.93 (5), p.322-328

1996

Volltextzugriff (PDF)

Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in M?re and Romsdal County, Norway

Neuroepidemiology, 2011-09, Vol.37 (1), p.58

2011

Volltextzugriff (PDF)

Vitamin D, HLA ‐ DRB 1 and Epstein–Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

European journal of neurology, 2016-06, Vol.23 (6), p.1064-1070

2016

Volltextzugriff (PDF)

Multiple sclerosis and cancer in Norway A retrospective cohort study

Acta neurologica Scandinavica, 1996-06, Vol.93 (6), p.411-415

1996

Volltextzugriff (PDF)

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway

Journal of neurology, neurosurgery and psychiatry, 1995-04, Vol.58 (4), p.417-421

1995

Volltextzugriff (PDF)

WT1 and interferon-[beta]-vitamin D association in MS: a longitudinal study

Acta neurologica Scandinavica, 2016-04, Vol.133 (4), p.309

2016

Volltextzugriff (PDF)

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

Cochrane database of systematic reviews, 2000-10, Vol.2013 (4), p.CD001331

2000

Volltextzugriff (PDF)

Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in Moere and Romsdal County, Norway

Neuroepidemiology, 2011-09, Vol.37 (1), p.58-63

2011

Volltextzugriff (PDF)

Early prognostic factors for disability in multiple sclerosis, a European multicenter study

Acta neurologica Scandinavica, 1992-03, Vol.85 (3), p.212-218

1992

Volltextzugriff (PDF)

Disability and mortality in multiple sclerosis in Western Norway

Acta neurologica Scandinavica, 1996-05, Vol.93 (5), p.307-314

1996

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and prevalence of multiple sclerosis in Norway

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway

Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in Møre and Romsdal County, Norway

WT1 and interferon-β-vitamin D association in MS: a longitudinal study

Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients

Opsoclonus myoclonus syndrome in two cases with neuroborreliosis

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study

Autoimmune encephalitis in Molde, Western Norway 2004-2017

Oligoclonal bands in cerebrospinal fluid:a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index

Multiple sclerosis and chronic inflammatory diseases A case-control study

Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in M?re and Romsdal County, Norway

Vitamin D, HLA ‐ DRB 1 and Epstein–Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

Multiple sclerosis and cancer in Norway A retrospective cohort study

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway

WT1 and interferon-[beta]-vitamin D association in MS: a longitudinal study

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

Incidence and Clinical Features of Amyotrophic Lateral Sclerosis in Moere and Romsdal County, Norway

Early prognostic factors for disability in multiple sclerosis, a European multicenter study

Disability and mortality in multiple sclerosis in Western Norway

Suchergebnisse filtern